Health
COVID-19 vaccine tested at Emory is safe, generates immune response, early results show – Mirage News
An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in production of…
An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in production of both binding and neutralizing antibodies in healthy adult volunteers, according to interim results of an ongoing phase 1 trial published today in the New England Journal of Medicine.
The experimental vaccine is being co-developed by researchers at NIAID and at Moderna, Inc. of Cambridge, Massachusetts. Manufactured by Moderna, mRNA-1273 is designe…
-
Noosa News22 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News23 hours agoRising talent shine at Noosa International Surfilm Festival 2025
-
Noosa News24 hours agoSearch for missing man after unattended dinghy found near Boondooma Dam in Proston, QLD
-
Business24 hours agoSuncorp shares push higher on big leadership news